Skip to main content
H

HCmed Innovations Co., Ltd. — Investor Relations & Filings

Ticker · 6934 TW Manufacturing
Open in API
Filings indexed 20 across all filing types
Latest filing 2026-04-29 Report Publication Anno…
Country TW Taiwan
Listing TW 6934

About HCmed Innovations Co., Ltd.

https://www.hcmed-inno.com

HCmed Innovations Co., Ltd. specializes in the development of advanced inhaled drug delivery platforms and drug-device combination products. The company provides comprehensive Contract Development and Manufacturing Organization (CDMO) services, supporting pharmaceutical partners from initial feasibility studies and device customization to clinical supply and commercialization. Its core product portfolio includes the Pulmogine vibrating mesh nebulizer and the AdheResp breath-actuated mesh nebulizer, which features integrated connectivity for treatment monitoring via mobile applications. These solutions target respiratory conditions such as asthma, COPD, cystic fibrosis, and pulmonary hypertension. HCmed’s technology emphasizes patient-centric design, utilizing breath-actuated mechanisms and smart digital health integration to enhance medication adherence and therapeutic efficacy in aerosol delivery.

Recent filings

Filing Released Lang Actions
公告115年第一季財務報告董事會預計召開日期為 115年5月7日
Report Publication Announcement Classification · 1% confidence The document is a brief announcement on the Taiwan MOPS system by the company’s CFO, notifying the market of the planned board meeting date to review and approve the first-quarter financial report. It contains no financial figures or the report itself, but simply gives the timing of the report’s board approval. Under the “menu vs meal” rule it is an announcement of report timing rather than the report itself, matching the Report Publication Announcement (RPA) category.
2026-04-29 Chinese
115年年報及股東會資料 — 2026_6934_20260529FE2.pdf
AGM Information Classification · 1% confidence The document is clearly titled as the “2026 Annual General Shareholders’ Meeting Meeting Handbook,” containing the AGM notice, agenda, report items, ratification items, discussion items, attachments (business report, audit committee review, auditor’s report, financial statements, remuneration report, and articles of incorporation amendments), and procedural rules. These materials are exactly the presentations and supporting documents for an Annual General Meeting, matching the definition of AGM Information (Code: AGM-R).
2026-04-28 English
115年年報及股東會資料 — 2026_6934_20260529F13.pdf
AGM Information Classification · 1% confidence The document is a comprehensive “議事手冊” (meeting handbook) for the company’s 115th shareholders’ (Annual General) meeting, including detailed agenda items, annual business report, audit committee report, auditor’s report, financial statements, remuneration report, and other attachments provided to shareholders at the AGM. It clearly constitutes the materials shared during the Annual General Meeting, matching the definition of AGM Information (AGM-R).
2026-04-28 Chinese
115年年報及股東會資料 — 2026_6934_20260529F02.pdf
AGM Information Classification · 1% confidence The document is a shareholders’ meeting handbook (“議事手冊”) for the company’s 115th Annual General Meeting, containing meeting agenda, proposals (report items, approval items, discussion items), and attachments for presentation at the AGM. It is not the full annual report itself but the materials provided for the AGM. Therefore it is classified as AGM Information (AGM-R).
2026-04-28 Chinese
115年年報及股東會資料 — 2026_6934_20260529F01.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a detailed shareholders’ meeting notice for the 115th Annual General Meeting of 心誠經行動醫電股份有限公司. It includes the meeting date, venue, agenda items (reporting, approval, discussion), proxy form instructions, attendance card, and proxy solicitation details. This aligns with the definition for Proxy Solicitation & Information Statement (materials sent to shareholders to provide information and request votes).
2026-04-28 Chinese
115年04月法人說明會簡報 — 693420260423E001.pdf
Investor Presentation Classification · 1% confidence The document is a slide presentation from an investor conference, containing forward-looking statements, company overview, pipeline, clinical study results, market strategy and financial/investor-focused content. It does not represent an official regulatory filing (10-K, IR, ER, etc.) but is a detailed investor presentation deck. Therefore, it should be classified as an Investor Presentation (IP).
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.